US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...
In the phase 4 FOREMOST trial, treatment with apremilast improved both clinical and patient-reported outcomes at week 16 among patients with early oligoarticular PsA.
Q3 2024 Earnings Conference Call October 15, 2024 8:30 AM ETCompany ParticipantsJessica Moore - Vice President, ...
Patients with rheumatoid arthritis (RA) undergoing standard-of-care treatment frequently have persisting pain.
Persistent pain is common in rheumatoid arthritis. But patient-reported outcomes tools can help clinicians determine a care plan.
Machine learning models may be a useful tool for psoriasis severity assessment in clinical settings, despite a need for further research.
Advice is also provided on treatment strategies and targets of therapy, assessment of response, combination and sequential therapies, and tapering of therapy. HCQ is recommended for all patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback